DIAGNOSTIC RADIONUCLIDE IMAGING OF AMYLOID: BIOLOGICAL TARGETING BY CIRCULATING HUMAN SERUM AMYLOID P COMPONENT
- 1 June 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8600) , 1413-1418
- https://doi.org/10.1016/s0140-6736(88)92235-0
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.Annals of the Rheumatic Diseases, 1987
- Survival of patients with primary (AL) amyloidosisThe American Journal of Medicine, 1987
- Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiencyClinical Rheumatology, 1987
- Treatment of al amyloidosis with melphalan, prednisone, and colchicineArthritis & Rheumatism, 1986
- Response of Primary Hepatic Amyloidosis to Melphalan and Prednisone: A Case Report and Review of the LiteratureMayo Clinic Proceedings, 1986
- Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicineThe American Journal of Medicine, 1985
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- Senile amyloidosis: a protean manifestation of the aging process.Journal of Clinical Pathology, 1980
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980